BioSig Technologies, Inc. announced its intention to offer shares of common stock through a public offering.
The offering is being managed by Clear Street and Needham & Company.
The net proceeds from the offering will be used for purchasing gold bullion and general corporate purposes.
Public Offering Announcement
BioSig Technologies intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be utilized for purchasing gold bullion and for general corporate purposes.
Offering Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC on December 17, 2024.
Prospectus Availability
Interested parties can obtain the preliminary prospectus supplement and accompanying base prospectus from the SEC's website or the offering managers.
- BioSig Technologies aims to raise capital through the public offering to support its investment policy and corporate operations.
- The Company's decision to offer shares implies confidence in its growth prospects and financial strategies.
The announcement of the proposed public offering reflects BioSig Technologies' strategic approach to capital-raising and business expansion. It highlights the Company's focus on diversifying investments and enhancing operational capabilities for future growth.